Fidelity Investments’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Fidelity Investments’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-757	Closed	-$106	–	5711
2024 Q1	$106	Buy	+757	New	+$149	﹤0.01%	4972
2022 Q1	–	Sell	-30	Closed	–	–	5608
2021 Q4	$0	Buy	+30	New	+$99	﹤0.01%	5061

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Fidelity Investments's GRTX Position: Q2 2024 in Review

Fidelity Investments sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 757 shares — an estimated $106 sold.

Fidelity Investments first reported a position in GRTX in Q4 2021 and held it in 2 quarters. The position peaked at $106 in Q1 2024. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Fidelity Investments reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Fidelity Investments sold 757 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $106.
Fidelity Investments first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Fidelity Investments's Galera Therapeutics, Inc. Common Stock position peaked at $106 in Q1 2024.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.